Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Drug Metabolism & Discovery ADMET

Albert Li's Biography



Albert Li, President and CEO, In Vitro ADMET Laboratories LLC

Dr. Li is the President, CEO and co-founder of In Vitro ADMET Laboratories LLC, Columbia, MD and Malden, MA. His research is focused on the development and application of human-based in vitro experimental models, especially primary cultured human hepatocytes, in the accurate assessment of human drug properties including metabolic fate, drug-drug interactions and drug toxicity. He was one of the first scientists to successfully cryopreserve human hepatocytes to retain properties of freshly isolated cells. He is the inventor of the novel Integrated Discrete Multiple Organ Co-culture (IdMOC) system which models an organism with multiple organs interconnected by the systemic circulation. The IdMOC system is patented in United States, Japan, China, and European Union.He has published approximately 160 research papers/book chapters/reviews and edited/co-edited 6 books in toxicology, drug metabolism, and cell biology.

Albert Li Image

Application of Human Hepatocytes in the Evaluation of Human-Specific Adverse Drug Properties in Drug Development

Thursday, 11 September 2014 at 14:20

Add to Calendar ▼2014-09-11 14:20:002014-09-11 15:20:00Europe/LondonApplication of Human Hepatocytes in the Evaluation of Human-Specific Adverse Drug Properties in Drug DevelopmentDrug Metabolism and Discovery ADMET in MumbaiMumbaiSELECTBIOenquiries@selectbiosciences.com


Add to Calendar ▼2014-09-11 00:00:002014-09-11 00:00:00Europe/LondonDrug Metabolism and Discovery ADMETDrug Metabolism and Discovery ADMET in MumbaiMumbaiSELECTBIOenquiries@selectbiosciences.com